Human Cell Co
- Biotech or pharma, therapeutic R&D
Human Cell Co. is developing HC202, a recombinant human nerve growth factor (NGF) optimized for topical use as a novel neuroprotective and neurorestorative agent with initial focus on glaucoma.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}